KRT18 and metabolic dysfunction-associated steatohepatitis: Our preliminary data, under approved IRB protocols, concurred with the findings where caspase-cleaved CK-18 fragments plasma levels were heightened in MASH patients in comparison to healthy controls, but not statistically different from those with MASH-related HCC.